On the other hand, we have generated cancer cell lines in which one of the ORC subunits, ORC1, ORC2, or ORC5, is mutationally inactivated by CRISPR–Cas9, and the cells are still viable and proliferate with DNA replication [23, 24]. The gene discussed is ORC2; the disease is cancer.